MISSISSAUGA, Ontario, Dec. 19, 2011 /CNW/ -Valeant Pharmaceuticals International, Inc. announced that effective December 16, 2011, the company completed its previously announced acquisition of Dermik, a dermatology unit of Sanofi.
About Valeant Pharmaceuticals International, Inc.
Valeant Pharmaceuticals International, Inc. (nyse/tsx:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com .
Contact Information: Laurie W. Little 949-461-6002 laurie.little@valeant.com
SOURCE Valeant Pharmaceuticals International, Inc.
SOURCE: Valeant Pharmaceuticals International, Inc.
